Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takayo Fukuda

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2013
[Oncogene and tumor suppressor gene]Takayo Fukuda, Anna Sedukhina, Tomohiko Ohta
Seikagaku. the Journal of Japanese Biochemical Society|September 21, 2012
[BRCA1 and DNA damage response]Anna Sedukhina, Takayo Fukuda, Tomohiko Ohta
Current Cancer Drug Targets|October 31, 2015
Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage ResponseTakayo Fukuda, Tomoko Tsuruga, Takako Kuroda, et al.
Molecular & Cellular Oncology|June 17, 2016
The BARD1/HP1 interaction: Another clue to heterochromatin involvement in homologous recombinationTakayo Fukuda, Tomoko Tsuruga, Takako Kuroda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2007
[A case of left breast cancer resulting in complete response by primary systemic therapy]Takayo Fukuda, Takanori Watanabe, Masanori Kawahara, et al.
Springerplus|July 29, 2015
Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, and vinorelbineTakayo Fukuda, Masahiko Tanabe, Kokoro Kobayashi, et al.
Breast Cancer (Tokyo, Japan)|July 16, 2014
The Japanese Breast Cancer Society Clinical Practice Guideline for pathological diagnosis of breast cancerRie Horii, Naoko Honma, Akiko Ogiya, et al.
Cancer Medicine|April 14, 2015
MED12 exon 2 mutations in phyllodes tumors of the breastSatoi Nagasawa, Ichiro Maeda, Takayo Fukuda, et al.
Cancer Research|January 31, 2015
Interaction of BARD1 and HP1 Is Required for BRCA1 Retention at Sites of DNA DamageWenwen Wu, Hiroyuki Nishikawa, Takayo Fukuda, et al.
Springerplus|March 31, 2016
Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtypeTakayo Fukuda, Rie Horii, Naoya Gomi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2013
[Oncogene and tumor suppressor gene]Takayo Fukuda, Anna Sedukhina, Tomohiko Ohta
Seikagaku. the Journal of Japanese Biochemical Society|September 21, 2012
[BRCA1 and DNA damage response]Anna Sedukhina, Takayo Fukuda, Tomohiko Ohta
Current Cancer Drug Targets|October 31, 2015
Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage ResponseTakayo Fukuda, Tomoko Tsuruga, Takako Kuroda, et al.
Molecular & Cellular Oncology|June 17, 2016
The BARD1/HP1 interaction: Another clue to heterochromatin involvement in homologous recombinationTakayo Fukuda, Tomoko Tsuruga, Takako Kuroda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2007
[A case of left breast cancer resulting in complete response by primary systemic therapy]Takayo Fukuda, Takanori Watanabe, Masanori Kawahara, et al.
Springerplus|July 29, 2015
Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, and vinorelbineTakayo Fukuda, Masahiko Tanabe, Kokoro Kobayashi, et al.
Breast Cancer (Tokyo, Japan)|July 16, 2014
The Japanese Breast Cancer Society Clinical Practice Guideline for pathological diagnosis of breast cancerRie Horii, Naoko Honma, Akiko Ogiya, et al.
Cancer Medicine|April 14, 2015
MED12 exon 2 mutations in phyllodes tumors of the breastSatoi Nagasawa, Ichiro Maeda, Takayo Fukuda, et al.
Cancer Research|January 31, 2015
Interaction of BARD1 and HP1 Is Required for BRCA1 Retention at Sites of DNA DamageWenwen Wu, Hiroyuki Nishikawa, Takayo Fukuda, et al.
Springerplus|March 31, 2016
Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtypeTakayo Fukuda, Rie Horii, Naoya Gomi, et al.
Pageof 2